EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 160 filers reported holding EPIZYME INC in Q2 2020. The put-call ratio across all filers is 0.16 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $50,000 | -59.3% | 20,000 | -16.8% | 0.00% | -66.7% |
| Q3 2021 | $123,000 | -43.3% | 24,037 | -8.1% | 0.00% | -40.0% |
| Q2 2021 | $217,000 | -1.4% | 26,161 | +3.7% | 0.01% | 0.0% |
| Q1 2021 | $220,000 | -20.6% | 25,227 | -1.2% | 0.01% | 0.0% |
| Q4 2020 | $277,000 | -15.0% | 25,534 | -6.5% | 0.01% | -44.4% |
| Q3 2020 | $326,000 | -10.7% | 27,304 | +20.1% | 0.01% | -10.0% |
| Q2 2020 | $365,000 | -6.2% | 22,725 | -9.4% | 0.01% | -33.3% |
| Q1 2020 | $389,000 | -47.3% | 25,077 | -16.4% | 0.02% | +25.0% |
| Q4 2019 | $738,000 | +10.1% | 30,000 | -53.8% | 0.01% | -14.3% |
| Q3 2019 | $670,000 | -17.9% | 65,000 | 0.0% | 0.01% | -36.4% |
| Q2 2019 | $816,000 | -12.2% | 65,000 | -13.3% | 0.02% | -4.3% |
| Q1 2019 | $929,000 | +77.3% | 75,000 | -11.8% | 0.02% | +4.5% |
| Q4 2018 | $524,000 | +23.6% | 85,000 | +112.5% | 0.02% | +100.0% |
| Q3 2018 | $424,000 | +14.6% | 40,000 | +46.3% | 0.01% | +22.2% |
| Q2 2018 | $370,000 | +39.1% | 27,341 | +82.3% | 0.01% | +12.5% |
| Q1 2018 | $266,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |